Published in N Engl J Med on May 02, 1985
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol (1987) 2.74
Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proc Natl Acad Sci U S A (1988) 2.12
Epstein-Barr virus and human diseases: recent advances in diagnosis. Clin Microbiol Rev (1988) 1.78
Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency. Proc Natl Acad Sci U S A (1988) 1.41
Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines. J Exp Med (1993) 1.08
Genetics of SCID. Ital J Pediatr (2010) 1.02
Clonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphoma. J Clin Invest (1987) 0.97
Clonal origins of lymphoproliferative disease induced by Epstein-Barr virus. J Virol (1986) 0.93
Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin. Am J Pathol (1995) 0.88
Pathologic findings in adenosine deaminase deficient-severe combined immunodeficiency. II. Thymus, spleen, lymph node, and gastrointestinal tract lymphoid tissue alterations. Am J Pathol (1989) 0.83
Nine-year microflora study of an isolator-maintained immunodeficient child. Appl Environ Microbiol (1985) 0.79
Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection. Am J Pathol (2003) 0.79
Characterization of plasma cell populations at autopsy after human allogeneic bone marrow transplantation. Am J Pathol (1986) 0.77
The diagnosis of Epstein-Barr virus-associated polymorphic B cell lymphoma in immunocompromised patients: Review of methods. Can J Infect Dis (1991) 0.75
Immunohistological studies of lymphoproliferative lesions in a fatal case of Epstein-Barr virus infection. J Clin Pathol (1986) 0.75
Acute monocytic leukemia in a dog with X-linked severe combined immunodeficiency. Clin Diagn Lab Immunol (1994) 0.75
Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet (1992) 11.38
Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A (1995) 8.16
Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child (1986) 7.39
Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science (2001) 7.17
Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell (1993) 6.83
Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med (1989) 6.66
Impaired energy homeostasis in C/EBP alpha knockout mice. Science (1995) 5.68
Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression. J Exp Med (1979) 5.19
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood (2001) 4.65
Uniparental disomy as a mechanism for human genetic disease. Am J Hum Genet (1988) 4.21
The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: their quantitative definition and relation to leukocyte dysfunction and clinical features. J Infect Dis (1985) 4.08
Metastatic prostate cancer in a transgenic mouse. Cancer Res (1996) 4.02
Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr (1981) 4.00
A monoclonal antibody to human acute lymphoblastic leukaemia antigen. Nature (1980) 3.90
Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell (1985) 3.86
Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens. J Immunol (1981) 3.69
Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature (1992) 3.54
Biology and clinical relevance of human natural killer cells. Blood (1990) 3.50
Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr (1981) 3.42
Monoclonal antibodies against rat immunoglobulin kappa chains. Hybridoma (1982) 3.36
Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis (1981) 3.30
Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat Genet (1995) 3.29
Pneumonia due to Chlamydia trachomatis in the immunocompromised (nude) mouse. J Infect Dis (1981) 3.19
Familial patterns of narcolepsy. Lancet (1989) 3.07
Genetic control of the immune response. The effect of thymectomy on the primary and secondary antibody response of mice to poly-L(tyr, glu)-poly-D, L-ala--poly-L-lys. J Exp Med (1972) 3.06
Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics (1983) 3.00
Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J Exp Med (1990) 2.79
The role of antibody in host defense against the agent of mouse pneumonitis. J Infect Dis (1982) 2.78
Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest (1985) 2.77
Comparison of reverse transcription-PCR with tissue culture and other rapid diagnostic assays for detection of type A influenza virus. J Clin Microbiol (1996) 2.77
Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus. A possible genetic predisposition to disease. N Engl J Med (1971) 2.69
Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol (1996) 2.68
Genetic control of the immune response. A selective defect in immunologic (IgG) memory in nonresponder mice. J Exp Med (1972) 2.60
Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature (1999) 2.60
HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep (1997) 2.59
TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. Proc Natl Acad Sci U S A (1997) 2.52
Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature (1985) 2.51
Comparison of rapid diagnostic techniques for respiratory syncytial and influenza A virus respiratory infections in young children. J Clin Microbiol (1993) 2.50
A 12 year review of the antibiotic management of Hemophilus influenzae meningitis. Comparison of ampicillin and conventional therapy including chloramphenicol. J Pediatr (1972) 2.48
CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice. Mol Cell Biol (1997) 2.44
Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J Clin Invest (1981) 2.34
Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. J Infect Dis (1984) 2.31
DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med (1992) 2.28
Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med (1992) 2.26
Prolonged pneumococcal meningitis due to an organism with increased resistance to penicillin. Pediatrics (1976) 2.22
Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res (1997) 2.16
Effect of stimulus bandwidth on the perception of /s/ in normal- and hearing-impaired children and adults. J Acoust Soc Am (2001) 2.11
Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor. Science (1994) 2.10
Cooperative calcium binding and ATPase activation in sarcoplasmic reticulum vesicles. J Biol Chem (1980) 2.10
Generalized lymphadenopathy in homosexual men. Ann Intern Med (1983) 2.09
DQ (rather than DR) gene marks susceptibility to narcolepsy. Lancet (1992) 2.08
Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. Clin Cancer Res (1997) 2.08
PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies. Hum Mol Genet (1999) 2.08
A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma. Clin Immunol (1999) 2.04
A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects. AIDS Res Hum Retroviruses (1994) 1.95
Phenotypic and functional heterogeneity of human cloned natural killer cell lines. Nature (1983) 1.93
A unique cell surface antigen identifying lymphoid malignancies of B cell origin. J Clin Invest (1981) 1.93
Genetic control of murine resistance to Toxoplasma gondii. Infect Immun (1978) 1.91
Complete DiGeorge syndrome: persistence of profound immunodeficiency. J Pediatr (1998) 1.90
Identification of HLA-B27M1 and -M2 cross-reactive antigens in Klebsiella, Shigella and Yersinia. Immunology (1984) 1.89
Developing gap in immunity to poliomyelitis in an urban area. JAMA (1969) 1.89
Strain-dependent differences in murine susceptibility to toxoplasma. Infect Immun (1976) 1.85
Müllerian-inhibiting substance function during mammalian sexual development. Cell (1994) 1.85
B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues. J Clin Invest (1997) 1.84
Analysis of T-cell receptor gene rearrangement and expression in human natural killer clones. Science (1985) 1.83
CD3-negative natural killer cells express zeta TCR as part of a novel molecular complex. Nature (1989) 1.82
Monoclonal antibody (B27M2) subdividing HLA-B27. Hum Immunol (1982) 1.81
Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol (1990) 1.80
Seroepidemiological and ecological studies of the adenovirus-associated satellite viruses. Infect Immun (1970) 1.78
Endemic infectious diseases of the Middle East. Rev Infect Dis (1991) 1.77
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab (1983) 1.77
Serotherapy of acute lymphoblastic leukemia with monoclonal antibody. Blood (1981) 1.77
Changing presentation of herpes simplex virus infection in neonates. J Infect Dis (1988) 1.76
Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev (1996) 1.75
Influenza virus infections in infants. Pediatr Infect Dis J (1997) 1.75
Epidemiologic observations of influenza B virus infections in Houston, Texas, 1976-1977. Am J Epidemiol (1980) 1.74
Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis. J Immunol (1990) 1.74
Influenza in children. Relationship to other respiratory agents. JAMA (1980) 1.73
Family studies define a new histocompatibility locus, SB, between HLA-DR and GLO. Nature (1981) 1.72
Establishment of a Ph1-positive human cell line (BV173). J Natl Cancer Inst (1983) 1.72
Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. J Clin Invest (1989) 1.72
Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J Infect Dis (1986) 1.72
Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol (2000) 1.70
Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet (1981) 1.70
Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis. Bone Marrow Transplant (2010) 1.68
Fc gamma receptor type III (CD16) is included in the zeta NK receptor complex expressed by human natural killer cells. Proc Natl Acad Sci U S A (1990) 1.66
Long-term platelet support of patients with aplastic anemia. Effect of splenectomy and steroid therapy. Ann Intern Med (1970) 1.66
Influenza: its control in persons and populations. J Infect Dis (1986) 1.65
Hypoparathyroidism and T cell immune defect in a patient with 10p deletion syndrome. J Pediatr (1986) 1.65
A subset of natural killer cells in peripheral blood displays a mature T cell phenotype. J Exp Med (1986) 1.63
Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function. J Exp Med (1983) 1.62
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission. J Clin Oncol (1998) 1.61
Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. Blood (2000) 1.60
Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci U S A (1994) 1.60
Pneumonic plague in monkeys. An electron microscopic study. Am J Pathol (1969) 1.60
Identification and molecular cloning of the human Blym transforming gene activated in Burkitt's lymphomas. Nature (1983) 1.58
Comparative expression of T9, T10, and Ia antigens on activated human T cell subsets. Hum Immunol (1981) 1.57
Cyclin-dependent kinase inhibitor expression in pulmonary Clara cells transformed with SV40 large T antigen in transgenic mice. Cell Growth Differ (1997) 1.57
Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage. Blood (1981) 1.57